Term ended Feb 14, 2025 · Medium confidence
20-year base term ended Feb 14, 2025
Held by Astellas US LLC
Filed Feb 28, 2019 as application 16/289,374 · Granted Mar 16, 2021
Base term, 20 years from filing
Today
Term ended Feb 14, 2025
2005
2026
Clock starts
Feb 14, 2005
Feb 14, 2005
Term ended
Feb 14, 2025
Feb 14, 2025
Granted
Mar 16, 2021
Mar 16, 2021
base term
after the term ends
fee events
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 7,538,211, US 7,579,456, US 7,803,931, US 8,236,773, US 8,436,164, US 9,617,546, to Feb 14, 2025. The term already ends on or before that date, so the cap shortened nothing.
1 of 1
Maintenance fees paid
One maintenance fee can end this term early, the one due 3.5 years from grant; the next one's grace period runs past the term end. This counts it if the record shows it paid.
11
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. Confidence: Medium. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Feb 14, 2005, when application 11/058,134, the earliest non-provisional in its chain, was filed (this one was filed Feb 28, 2019); a parent in its chain could not be resolved (the next row) | Feb 14, 2025 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 7,538,211, US 7,579,456, US 7,803,931, US 8,236,773, US 8,436,164, US 9,617,546) | resolves to Feb 14, 2025, no earlier than this term, so no change | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 1 maintenance fees paid | term ended | High confidence |
| Computed term end | The steps above, in order | Feb 14, 2025 | Medium confidence |
This family
| US 7,803,931 | Term ended Feb 2025 | Feb 2025 |
| US 7,538,211 | Term ended Feb 2025 | Feb 2025 |
| US 7,579,456 | Term ended no later than Feb 2025 | no later than Feb 2025 |
| US 8,236,773 | Term ended Nov 2026 | Nov 2026 |
| US 8,436,164 | Term ended Feb 2025 | Feb 2025 |
| US 9,617,546 | Term ended no later than Feb 2025 | no later than Feb 2025 |
| US 10,947,544 | this patent Feb 2025 | Feb 2025 |
| US 11,913,000 | Term ended Apr 2025 | Apr 2025 |
8 of 11 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Aug 5, 2022 Reel 61088, frame 48 | Iveric Bio, Inc. | Hercules Capital, Inc. | Security Interest |
| Jun 29, 2023 Reel 64114, frame 743 | Benedict, Claude; Epstein, David; Wilson, Charles; McCauley, Dilara; Kurz, Jeffrey; Kurz, Markus; McCauley, Thomas Greene; Rottman, James | Archemix Corp. | Assignment of Assignor's Interest |
| Jun 29, 2023 Reel 64115, frame 418 | Archemix Corp. | Archemix LLC | Merger |
| Jul 17, 2023 Reel 64286, frame 472 | Hercules Capital, Inc. | Iveric Bio, Inc.; Iveric Bio Gene Therapy LLC; Orion Ophthalmology LLC | Release of Security Interest |
| Jul 17, 2023 reel/frame not recorded | Hercules Capital, Inc. | Iveric Bio, Inc. | Release of Security Interest |
| Jul 17, 2023 reel/frame not recorded | Hercules Capital, Inc. | Iveric Bio Gene Therapy LLC | Release of Security Interest |
| Jul 17, 2023 reel/frame not recorded | Hercules Capital, Inc. | Orion Ophthalmology LLC | Release of Security Interest |
| Sep 7, 2023 Reel 64834, frame 160 | Archemix LLC | Iveric Bio., Inc. | Assignment of Assignor's Interest |
| Jun 26, 2024 Reel 67851, frame 643 | Iveric Bio, Inc. | Astellas US LLC | Merger |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 7,538,211, US 7,579,456, US 7,803,931, US 8,236,773, US 8,436,164, US 9,617,546, ends no earlier than this term, so it caps nothing.
Citations
0
later US patents cite this one
That is below the median of utility patents granted in 2021 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.